✦ LIBER ✦

Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non ST-Segment Elevation Acute Coronary Syndrome: Results From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial

✍ Scribed by Scirica, B. M.; Morrow, D. A.; Hod, H.; Murphy, S. A.; Belardinelli, L.; Hedgepeth, C. M.; Molhoek, P.; Verheugt, F. W.A.; Gersh, B. J.; McCabe, C. H.; Braunwald, E.

Book ID: 125438083
Publisher: Lippincott Williams and Wilkins
Year: 2007
Tongue: English
Weight: 364 KB
Volume: 116
Category: Article
ISSN: 0009-7322
DOI: 10.1161/circulationaha.107.724880

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B-Type Natriuretic Peptide and the Effec

B-Type Natriuretic Peptide and the Effect of Ranolazine in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Observations From the MERLIN–TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary–Thrombolysis In Myocardial Infarction 36) Trial

✍ David A. Morrow; Benjamin M. Scirica; Marc S. Sabatine; James A. de Lemos; Sabin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Ischemia Detected on Continuous Electroc

Ischemia Detected on Continuous Electrocardiography After Acute Coronary Syndrome: Observations From the MERLIN–TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis In Myocardial Infarction 36) Trial

✍ Benjamin M. Scirica; David A. Morrow; Andrzej Budaj; Anthony J. Dalby; Satishkum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 897 KB

Efficacy of Ranolazine in Patients With

Efficacy of Ranolazine in Patients With Chronic Angina: Observations From the Randomized, Double-Blind, Placebo-Controlled MERLIN–TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Segment Elevation Acute Coronary Syndromes) 36 Trial

✍ Sean R. Wilson; Benjamin M. Scirica; Eugene Braunwald; Sabina A. Murphy; Ewa Kar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Evaluation of a novel anti-ischemic agen

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non–ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial

✍ David A. Morrow; Benjamin M. Scirica; Ewa Karwatowska-Prokopczuk; Allan Skene; C 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Evaluation of a novel anti-ischemic agen

✍ David A. Morrow; Benjamin M. Scirica; Ewa Karwatowska-Prokopczuk; Allan Skene; C 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 205 KB

T-WAVE ALTERNANS (TWA) IS ASSOCIATED WIT

T-WAVE ALTERNANS (TWA) IS ASSOCIATED WITH CARDIOVASCULAR MORTALITY AND NSVT IN THE MERLIN-TIMI 36 TRIAL OF RANOLAZINE VERSUS PLACEBO IN PATIENTS WITH NON-ST SEGMENT elevation ACUTE CORONARY SYNDROME

✍ Scirica, Benjamin; Nieminen, Tuomo; Pegler, Jose RM; Tavares, Caio; Pagotto, Vit 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 147 KB